Now showing items 41-60 of 75

    Issue DateTitleAuthor(s)
    18 May 2017Pleiotropic Effects of Trait-Associated Genetic Variation on DNA Methylation: Utility for Refining GWAS Loci  Hannon, E; Weedon, M; Bray, N; et al.
    2 March 2022PLIN1 haploinsufficiency causes a favorable metabolic profile  Patel, KA; Burman, S; Laver, TW; et al.
    17 July 2018PLIN1 haploinsufficiency is not associated with lipodystrophy  Laver, TW; Patel, KA; Colclough, K; et al.
    3 April 2017Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2.  Cabezas, OR; Flanagan, SE; Stanescu, H; et al.
    21 July 2017Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients  Shields, B; Shepherd, M; Hudson, M; et al.
    23 May 2013Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency.  Murray, A; Schoemaker, MJ; Bennett, CE; et al.
    18 September 2020Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes  Delgado, J; Jones, L; Bradley, MC; et al.
    28 April 2016Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis  Hope, SV; Wienand-Barnett, S; Shepherd, M; et al.
    28 April 2016Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis  Hope, Suzy; Wienand-Barnett, Sophie; Shepherd, Maggie H.; et al.
    25 June 2015Practical considerations in improving research through public involvement  Jenner, MK; Gilchrist, M; Baker, GC
    17 March 2017Precision diabetes: learning from monogenic diabetes  Hattersley, AT; Patel, KA
    31 January 2018Precision medicine in Type 2 diabetes: Clinical markers of insulin resistance are associated with altered short and long-term glycemic response to DPP4-inhibitor therapy  Dennis, J; Shields, B; Hill, A; et al.
    30 September 2019Precision medicine in type 2 diabetes: harnessing individual-level trial data alongside routine care records to identify predictors of response to SGLT2 inhibitors and DPP4 inhibitors  Dennis, JM; Henley, W; Jones, A; et al.
    25 August 2020Precision medicine in type 2 diabetes: Using individualised prediction models to optimise selection of treatment  Dennis, JM
    2 April 2020Predicting incident delirium diagnoses using data from primary-care electronic health records  Bowman, K; Jones, L; Masoli, J; et al.
    8 November 2021Predicting novel candidate human obesity genes and their site of action by systematic functional screening in Drosophila.  Agrawal, N; Lawler, K; Davidson, CM; et al.
    21 July 2020Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus – A MASTERMIND precision medicine approach (UKPDS 87)  Agbaje, OF; Coleman, RL; Hattersley, AT; et al.
    27 February 2019Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study  Kennedy, NA; Heap, GA; Green, HD; et al.
    20 July 2020Preexisting comorbidities predicting Covid-19 and mortality in the UK biobank community cohort  Atkins, J; Masoli, J; Correa-Delgado, J; et al.
    1 September 2016Prematurity should not prevent genetic testing for neonatal diabetes  Besser, RE; Flanagan, SE; Mackay, DG; et al.